Frederiksberg, Denmark

Nils Gjerlov Hansen

This inventor holds 1 USPTO granted patent. Top assignee: Church Dwight & Co., Inc.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nils Gjerlov Hansen: Innovator in Controlled Release Preparations

Introduction

Nils Gjerlov Hansen is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of pharmaceutical preparations, particularly in the area of controlled release formulations. His work focuses on enhancing the efficacy of potassium supplementation and addressing degenerative diseases.

Latest Patents

Hansen holds a patent for "Alkalinizing potassium salt controlled release preparations." This invention involves multiparticulate controlled release preparations that incorporate an alkalinizing potassium salt, preferably potassium bicarbonate, as an active ingredient. These preparations are designed for oral administration and are particularly useful for potassium supplementation and the treatment of degenerative bone or cardiovascular diseases, such as osteoporosis and hypertension. He has 1 patent to his name.

Career Highlights

Nils Gjerlov Hansen is associated with Church & Dwight Co., Inc., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that improve patient outcomes.

Collaborations

Hansen has collaborated with notable colleagues, including Poul Bertelsen and Herman L. Marder, to further enhance the development of pharmaceutical products.

Conclusion

Nils Gjerlov Hansen's contributions to controlled release preparations highlight his commitment to improving health outcomes through innovative pharmaceutical solutions. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…